Technical Analysis for SGFEF - Siegfried Hldg Ltd

Grade Last Price % Change Price Change
grade B 386.0 -1.72% -6.7500
SGFEF closed down 1.72 percent on Thursday, June 28, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical SGFEF trend table...

Date Alert Name Type % Chg

Older signals for SGFEF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Siegfried Holding AG engages in the life sciences business worldwide. It develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling liquid dosage forms. The company offers custom API and intermediate synthesis services, including process and chemical development, analytical development, pilot manufacturing and scale up, and commercial manufacturing; and contract development and manufacturing services, such as pharmaceutical and analytical development, scale up and clinical trial material production, process and analytical transfer, and commercial manufacturing and packaging. It also provides APIs and controlled substances focusing on anesthetics, pain/addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. The company's product portfolio for multi clients comprises opiate derivatives used in strong pain killers primarily for cancer therapy, as well as APIs that include methadone and nicotine used in addiction therapy. In addition, it licenses solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Manufacturing RTT Cancer Euphoriants Drugs Pain Psychoactive Drugs Active Pharmaceutical Ingredients Api Heroin Opioids Cancer Therapy Treating Cancer Eli Lilly And Company Manufacturing Services Nicotine Drug Rehabilitation Addiction Sterile Products Methadone
Is SGFEF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 392.75
52 Week Low 386.0
Average Volume 100
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 386.0000
Resistance 3 (R3) 386.0000 386.0000 386.0000
Resistance 2 (R2) 386.0000 386.0000 386.0000 386.0000
Resistance 1 (R1) 386.0000 386.0000 386.0000 386.0000 386.0000
Pivot Point 386.0000 386.0000 386.0000 386.0000 386.0000
Support 1 (S1) 386.0000 386.0000 386.0000 386.0000 386.0000
Support 2 (S2) 386.0000 386.0000 386.0000 386.0000
Support 3 (S3) 386.0000 386.0000 386.0000
Support 4 (S4) 386.0000